us-abim MCQ (SBA): T2DM-Cardiorenal Risk Reduction

Instant feedback + full explanation. One question, done properly.

ModerateEndocrinologyT2DM-Cardiorenal Risk Reductionus-abimus-usmle-step-3

A 58-year-old with type 2 diabetes (A1C 8.1%), ASCVD (prior MI), and eGFR 62 mL/min/1.73 m² is on metformin. Which add-on agent provides proven CV benefit?

Educational content. Not a substitute for clinical judgement or local policy.

us-abim MCQ: T2DM-Cardiorenal Risk Reduction — Answer & Explanation |